![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 37, 26217-26224, September 10, 1999
,
¶
From the
Department of Biochemistry and Molecular
Biology, Mount Sinai School of Medicine, New York, New York 10029 and
the § Department of Biochemistry and Molecular Biology,
Albany Medical College, Albany, New York 12208
| |
ABSTRACT |
|---|
|
|
|---|
HepG2 cells were transfected with vectors
containing human catalase cDNA and catalase cDNA with a
mitochondrial leader sequence to allow comparison of the effectiveness
of catalase overexpressed in the cytosolic or mitochondrial
compartments to protect against oxidant-induced injury. Overexpression
of catalase in cytosol and in mitochondria was confirmed by Western
blot, and activity measurement and stable cell lines were established.
The intracellular level of H2O2 induced
by exogenously added H2O2 or antimycin A was
lower in C33 cell lines overexpressing catalase in the cytosol and mC5
cell lines overexpressing catalase in the mitochondria as compared with
Hp cell lines transfected with empty vector. Cell death caused by
H2O2, antimycin A, and menadione was
considerably suppressed in both the mC5 and C33 cell lines. C33 and mC5
cells were also more resistant to apoptosis induced by
H2O2 and to the loss of mitochondrial membrane
potential induced by H2O2 and antimycin A. In
view of the comparable protection by catalase overexpressed in the
cytosol versus the mitochondria, catalase produced in both cellular compartments might act as a sink to decompose
H2O2 and move diffusable
H2O2 down its concentration gradient. The
present study suggests that catalase in cytosol and catalase in
mitochondria are capable of protecting HepG2 cells against cytotoxicity
or apoptosis induced by oxidative stress.
Hydrogen peroxide (H2O2), one of the major
reactive oxygen species
(ROS),1 is produced at a
relatively high rate as a product of aerobic metabolism. Under normal
conditions, 1-2% of the oxygen reduced by mitochondria may be
converted to O Pathological conditions, which increase the rate of
H2O2 production or deplete components of the
anti-oxidant system, e.g. GSH, will lead to the accumulation
of H2O2 in the cytosol or mitochondria. In
biological systems, H2O2 could readily diffuse
across cellular membranes and lead to depletion of ATP, GSH, and NADPH.
It could also induce a rise in free cytosolic Ca2+ and
activate poly(ADP-ribose) polymerase activity and cause DNA damage (7).
By scission of the peroxide bond through the Fenton reaction, hydrogen
peroxide could generate hydroxyl radical, an extremely potent oxidant
(5, 8). The hydroxyl radical is able to cause the degradation of most
biological macromolecules, e.g. peroxidation of lipids,
oxidation of sugars and of protein thiols, DNA base damage, and strand
breakage of nucleic acids (9).
Low levels of H2O2 have been shown to trigger
apoptosis, while high levels lead to necrosis (10, 11). Many reports
indicate that hydrogen peroxide plays a very crucial role in
cytotoxicity and apoptosis induced by stimuli such as ceramide (12),
Antimycin A (AA) (13), arsenite (14), and tumor necrosis factor- Mitochondria are a main target for damage by ROS. Hydrogen peroxide is
know to induce a mitochondrial permeability transition and disrupt the
mitochondrial membrane potential ( Reagents--
Rhodamine 123 (Rh123), propidium iodide (PI), and
2',7'-dichlorofluorescein diacetate (DCF-DA) were purchased from
Molecular Probes (Eugene, OR). Polyclonal antibody raised in rabbit
against human catalase was obtained from Calbiochem. Zeocin for cloning selection was from Invitrogen. Hydrogen peroxide, AA, horseradish peroxidase conjugated to goat anti-rabbit IgG, MEM, fetal bovine serum,
and trypan blue were purchased from Sigma.
Plasmid Construction--
The pCAT10 plasmid containing the
human catalase cDNA was obtained from American Type Culture
Collection. PZeoSV2(+) mammalian expression vector was obtained from
Invitrogen Corporation (San Diego, CA). A 900-base pair fragment
containing the MnSOD mitochondrial signal peptide was PCR-amplified
with HindIII-SalI ends from pRCMV/MnSOD (22). The
resulting product was inserted into the pCR2.1 TA cloning vector
(Invitrogen Corp.). A 1-kilobase pair fragment containing the
mitochondrial signal peptide and the CMV promoter region of pCR/CMV
plasmid was then removed from the resulting plasmid by digestion with
HindIII, which cleaves at the newly introduced
HindIII site and the naturally occurring HindIII
3' site in the MnSOD cDNA. This fragment was ligated into the
pZeoSV2(+), precut with HindIII. The new PZeoSV-MSP was
digested with BsaI, removing the CMV promoter region, and
religated. The final pZeoSV-MSP was then digested with
HindIII and NotI. The human fibroblast catalase
cDNA from pCAT10 was equipped with a HindIII site at the
5' end and a NotI site at the 3' end with oligonucleotide linkers using PCR. The resulted 1.6-kilobase pair PCR product was
ligated in frame into the pZeoSV-MSP to obtain the final recombinant plasmid pZeoSV/MSP-CAT. The mammalian expression vector pZeoSV-CAT was
created by inserting the 1.6-kilobase pair catalase fragment into
pZeoSV2(+) precut with HindIII and NotI. Each DNA
insert was sequenced bidirectionally by using the Taq
DyeDeoxy terminator cycle sequencing kit and an ABI model 310 DNA
sequencer (Applied Biosystems).
Cell Culture and Transfection--
HepG2 cells (from ATCC) were
cultured in MEM containing 10% fetal calf serum, 100 units/ml
penicillin, 100 µg/ml streptomycin, and 2 mM glutamine in
a humidified atmosphere, in 5% CO2, at 37 °C. Before
transfection, 5× 105 HepG2 cells were seeded onto 10-cm
culture dishes and grown to 60% confluence. The expression plasmid
vectors pZeoSV2(+), pZeoSV2(+) containing human catalase cDNA
(pZeoSV-CAT), as well as pZeoSV2(+) containing human catalase cDNA
with a MnSOD mitochondrial leader sequence (pZeoSV/MSP-CAT) were
transfected into HepG2 cells using the DOTAP transfection reagent
(Roche Molecular Biochemicals) according to the instructions provided
by the manufacturer. Forty-eight hours after transfection, cells were
trypsinized and seeded at a low cell density onto 10-cm culture dishes
in 10% fetal bovine serum plus MEM containing 300 µg/ml Zeocin.
HepG2 cells not subject to transfection were cultured with the same
concentration of Zeocin medium as a control for selection. Two weeks
after transfection, the surviving clones were isolated, transferred to
24-well plates, and grown to large scale. Catalase expression in each
clone was measured by Western blot and assays of activity. Stable cell
lines with overexpression of catalase in the cytosol and in the
mitochondria, as well as cells transfected with the empty vector, were
selected and maintained in MEM containing 300 µg/ml Zeocin.
Preparation of Mitochondria--
Mitochondria were prepared by
discontinuous Percoll gradient centrifugation using a modification of
the method of Sims (23). Five 10-cm culture dishes of cells grown to
80% confluence were washed twice with PBS, scraped from the dishes,
and suspended in 1 ml of cold isolation buffer (0.32 M
sucrose, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4).
Cells were homogenized using a glass homogenizer. The homogenate was
centrifuged at 1330 × g for 5 min at 4 °C. The
supernatants were centrifuged at 21,200 × g for 10 min
at 4 °C. The pellet was suspended in a 15% Percoll solution, and aliquots were layered onto discontinuous Percoll gradients (23% over
40%) and then centrifuged for 15 min at 30,700 × g at
4 °C. The dense band of material at the interface between the 23%
and 40% Percoll layers was collected, diluted 1:4 in fresh isolation buffer, and then centrifuged for 10 min at 16,700 × g
at 4 °C. The pellet was resuspended in 2 ml of isolation buffer and
centrifuged again for 10 min at 6900 × g. The
mitochondrial pellet was suspended in 100 µl of PBS and used for
Western blot analysis or catalase activity assay.
Western Blot--
To assay for total cellular catalase protein
levels, cells were grown to 80% confluence in 10-cm dishes, washed
twice with PBS, harvested by scraping, and subsequently sonicated at
duty cycle 50% and output control 4 for 20 s. To assay for
mitochondrial catalase protein levels, the intact mitochondria prepared
as described above were sonicated (Heat Systems-Ultrasonics, Inc.) at
duty cycle 30 and output control 3 for 10 s. The sonicated
suspensions were centrifuged at 8000 × g for 10 min at
4 °C. The supernatant was transferred to a new tube, and the protein
concentration was measured (DC protein assay reagent, Bio-Rad). Ten
µg of denatured protein were resolved on 10% SDS-PAGE and
electroblotted onto nitrocellulose membranes (Bio-Rad). The membrane
was incubated with rabbit anti-human catalase polyclonal antibody as
the primary antibody (1:1000), followed by incubation with horseradish
peroxidase conjugated to goat anti-rabbit IgG (Sigma) as the second
antibody (1:5000). Detection by the chemiluminescence reaction was
carried out for 1 min using the ECL kit (Amersham Pharmacia Biotech), followed by exposure to Kodak X-Omat x-ray film (Eastman Kodak Co.).
Catalase Activity Assay--
Fresh sonicated extracts from cells
and mitochondria were used. Catalase activity was determined at
25 °C according to Claiborne and Fridovich (24). The decomposition
of hydrogen peroxide by catalase was followed by ultraviolet
spectroscopy at 240 nm. The reaction was performed using a solution of
20 mM hydrogen peroxide in 50 mM
KH2PO4 containing 10 µg of total cellular or
mitochondrial protein in a final volume of 1 ml. Specific activity of
catalase was calculated from the equation: specific activity (units/mg of protein/min) = Intracellular H2O2
Measurement--
Fluorescence spectrophotometry and confocal
microscopy were used to measure intracellular
H2O2, with 2',7'-DCF-DA as the probe. DCF-DA
readily diffuses through the cell membrane and is enzymatically hydrolyzed by intracellular esterases to the nonfluorescent DCFH, which
can then be rapidly oxidized to highly fluorescent DCF in the presence
of ROS. Cells incubated in medium alone or cells treated with
H2O2 or AA were incubated with 5 µM DCF-DA in MEM for 30 min at 37 °C in the dark. The
cells were washed in PBS, trypsinized, resuspended in 3 ml of PBS, and
the intensity of fluorescence was immediately read in a fluorescence
spectrophotometer (Perkin-Elmer 650-10S, Hitachi, Ltd.) at 503 nm for
excitation and at 529 nm for emission. For confocal microscopy, slides
with control, non-treated cells or cells treated with
H2O2 and DCF-DA were washed in PBS and covered
with glass covers, followed by observation under a confocal microscope.
Cell Viability--
Cell viability was measured either by trypan
blue exclusion or by vital dye reduction. For menadione toxicity
experiments, the cell titer 96 nonradioactive cell proliferation assay
kit (Promega) as described by Chen et al. (25) was used.
1 × 105 cells were seeded onto 24-well plates and
incubated with medium containing different concentrations of menadione
for 18 h. After addition of the "stop" solution, the
absorbance of the reaction solution at 570 nm was recorded. The
absorbance at 630 nm was used as reference. The net
A570
For experiments involving toxicity of H2O2 and
AA, cell viability was detected by the trypan blue exclusion assay. 1×
105 cells were seeded onto 24-well plates and first
incubated with medium containing 0.3 mM BSO for 16 h,
followed by incubation with medium containing 100 µM
H2O2 or 15 µM AA. At different
time points, cells were trypsinized and diluted followed by staining with 0.2% trypan blue. The number of cells excluding trypan blue or
staining with trypan blue were counted under the light microscope. The
percentage of cells excluding trypan blue was taken as an index of cell
viability. Cell morphology was also visualized under the light
microscope, and pictures were taken.
Apoptosis Assay--
The DNA fragmentation pattern (DNA ladder)
was carried out by agarose gel electrophoresis. Cells (1×
106) were scraped and centrifuged at 1200 rpm for 10 min.
The cell pellet was resuspended in 1 ml of lysis buffer consisting of
10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM EDTA, 100 µg/ml proteinase K, and 0.5% SDS and
incubated for 2 h at 50 °C. DNA was extracted with 1 ml of
phenol, pH 8.0, followed by extraction with 1 ml of phenol/chloroform
(1:1) and chloroform. The aqueous phase was precipitated with 2.5 volumes of ice-cold ethanol and 0.1 volume of 3 M sodium
acetate, pH 5.2, at
DNA analysis by flow cytometry was used to quantify the percentage of
apoptotic cells. 5 × 105 cells were seeded onto
six-well plates and incubated with medium containing 0.3 mM
BSO for 16 h, followed by treatment with 100 µM
H2O2. At different time points, cells were
harvested by trypsinization, washed with PBS, followed by
centrifugation at 2000 rpm for 10 min. The pellet of cells was
resuspended in 80% ethanol and stored at 4 °C for 24 h. Cells
were washed twice with PBS. The pellet was resuspended in PBS
containing 100 µg/ml RNase A, incubated at 37 °C for 30 min,
stained with PI (50 µg/ml), and analyzed by flow cytometry for DNA analysis.
Flow Cytometry Analysis of the Mitochondrial Membrane
Potential--
Changes in the integrity of the plasma membrane and in
the mitochondrial membrane potential were examined by monitoring the cells after double staining with PI and Rh123. Cells (5 × 105) were seeded onto six-well plates and incubated with
medium containing 0.3 mM BSO for 16 h followed by
treatment with 100 µM H2O2 or 15 µM AA for different times. The cells were then incubated
with medium containing 5 µg/ml Rh123 for 1 h. Cells were
harvested by trypsinization, and resuspended in 1 ml of MEM containing
5 µg of PI. The intensity of fluorescence from PI and Rh123 was analyzed by flow cytometry.
Overexpression of Catalase in Cytosol and in
Mitochondria--
Surviving clones of HepG2 cells transfected with the
empty plasmid, or plasmid containing human catalase cDNA, or
plasmid containing catalase cDNA with a 80-base pair MnSOD
mitochondrial leader sequence were assayed for catalase expression by
Western blot and catalase catalytic activity. Two high expression
cytosol catalase clones (C1 and C33) and two high expression
mitochondrial catalase clones (mC5 and mC26) were selected for detailed
evaluation. Fig. 1 shows the expression
of catalase in the total cell extract (panel a)
and in the mitochondrial extract (panel b) from
these cells and cells transfected with empty vector (Hp) as well as the
parental HepG2 cells as determined by Western blot. Results from
densitometric analyses of the intensity of the various bands indicated
that the expression of catalase in total cell extracts of cell lines
C1, C33, mC5, and mC26 was about 2-fold higher than that in the Hp
cells and the parental HepG2 cells. A high amount of catalase was found
in the mitochondrial extracts from mC5 and mC26 cells, but very low
levels of catalase were present in the mitochondrial extracts from C1,
C33, Hp, and parental HepG2 cells. The catalase content in
mitochondrial extracts from mC5 and mC26 cells was about 20-fold higher
than that in HepG2 cells and at least 5-10-fold higher than the other
transfected cell lines. The same results were obtained for the catalase
activity assay (Fig. 2). The catalase
activity in total extracts of cell lines C1, C33, mC5, and mC26 was
2-3-fold higher than that of the control cell line Hp and parental
HepG2 cells. With respect to catalase activity in the mitochondria,
high activity was found only in the mitochondrial extracts of cell
lines mC5 and mC26. For the experiments shown below, results were
compared between C33, mC5, and Hp cell lines, in order to assess the
effectiveness of mitochondrially expressed catalase with that of
cytosolically expressed catalase in protecting against oxidative stress
and cellular toxicity.
Intracellular H2O2--
Fig.
3A shows the result of
intracellular H2O2 levels in cell lines C33,
mC5, Hp, and parental HepG2 cells as determined by fluorescence
spectrophotometry using the oxidant-sensitive dye 2',7'-DCF-DA. Higher
H2O2 levels were detected in Hp cells and HepG2
cells than that found in C33 and mC5 cells after treatment with either
500 µM H2O2 or 15 µM AA for 2 h followed by incubation with 5 µM 2',7'-DCF-DA for 30 min. Cytosolic and mitochondrial expressed catalase were equally effective in lowering the fluorescence associated with oxidation of DCFH after treatment with either H2O2 or AA. We also analyzed the intracellular
level of H2O2 by confocal microscopy after
treating cells with 500 µM H2O2
for 2 h, followed by incubation with 2',7'-DCF-DA (Fig.
3B). The intensity of fluorescence in Hp cells was much
stronger than that observed for the C33 and mC5 cells.
Suppression of Menadione-, H2O2-, and
Antimycin A-induced Cytotoxicity--
The
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium assay was used to
determine the cytotoxicity induced by the redox cycling agent,
menadione. HepG2, Hp, C33, and mC5 cells were treated with different
concentrations (0-20 µM) of menadione for 18 h, and
the viability of the cells was determined. The percentage of surviving
cells decreased in a dose-dependent manner, and the decrease was similar for the parental HepG2 cells and the Hp cell line
(Fig. 4). mC5 cells were more resistant
to the cytotoxic effects of menadione than Hp and wild HepG2 cells, and
C33 cells were even more resistant. The resistance against menadione
toxicity by the mC5 cells was maintained up to menadione concentrations of 15 µM but then decreased at the menadione
concentration of 20 µM; C33 cells still showed strong
resistance even at 20 µM menadione.
A trypan blue exclusion assay was used to detect the cytotoxicity
induced by H2O2 and AA. In order to show the
maximum protective effects of catalase and to lower the influence of
the GSH system, BSO, an inhibitor of the synthesis of glutathione, was
used to lower the level of GSH in the cells. Hp, C33, and mC5 cells
were pretreated with 0.3 mM BSO for 16 h, followed by
incubation with 100 µM H2O2 or 15 µM AA for different times. The number of surviving Hp
cells rapidly decreased after 8 h of incubation with 100 µM H2O2, and almost none of the
Hp cells were viable after 48 h (Fig. 5a). Both C33 and mC5 cells
showed a comparable resistance to the cytotoxic effects of
H2O2 as compared with the Hp cells; 60-70% of
cells were still viable even after 48 h of treatment with
H2O2 (Fig. 5a). Hp cells were also
quite sensitive to toxicity by 15 µM AA, as only 50% of
cells were viable after 4 h of treatment while few cells were
alive after 12 h (Fig. 5b). Both C33 and mC5 cells were
significantly resistant to the toxicity of AA, with about 85% and 50%
of cells viable after 4 and 12 h treatment, respectively (Fig.
5b). There is no significant difference between C33 and mC5
cells in protecting against the toxicity induced by 100 µM H2O2 or 15 µM
AA. Essentially similar results were obtained after morphological
visualization of the cells under the light microscope (data not shown).
Most of the Hp cells lost normal morphology when treated with
H2O2 for 24 h or AA for 12 h, whereas the C33 cells and the mC5 cells retained their shape and structure.
DNA Fragmentation Induced by H2O2--
DNA
ladders are believed to be a biochemical marker for apoptosis. The
cells were pretreated with 0.3 mM BSO for 16 h,
followed by incubation with 100 µM
H2O2 for 48 h. The DNA was isolated and
electrophoresed on a 1.5% agarose gel. Hp and parental HepG2 cells
showed a clear DNA ladder in response to the
H2O2 treatment, whereas no DNA ladder was seen
in either the C33 or the mC5 cells (Fig.
6).
DNA analysis by flow cytometry after staining with PI was used to
measure the percentage of apoptotic cells. Hp, C33, and mC5 cells were
pretreated with 0.3 mM BSO for 16 h, followed by incubation with 100 µM H2O2 for
0, 4, 8, 12, and 24 h. DNA analysis was carried out as described
under "Materials and Methods." There were less than 5% apoptotic
cells after the BSO treatment for all three cell lines not incubated
with the H2O2 (0 h samples) (Fig.
7, A, panels
a-c, and B, bar graph 2).
In the Hp cells, the percentage of apoptotic cells increased to 17%,
40%, and 48% after 8, 12, and 24 h of treatment with
H2O2, respectively (Fig. 7B,
bar graphs 4-6; A,
panels d and g show the 8- and 24-h
data). The C33 and mC5 cells were resistant to the
H2O2-induced apoptosis, e.g. after
the 24-h treatment, the percentage of apoptotic cells was 48% in Hp
cells and only 17% and 6% in C33 and mC5, cells respectively (Fig. 7,
A, panels g-i; B,
bar graph 6).
Mitochondrial Membrane Potential ( Because mitochondria are an important target for interaction with
H2O2 and since these organelles lack catalase,
we developed a HepG2 cell line that expresses catalase in mitochondria
by transferring a plasmid containing catalase cDNA with the peptide
leader sequence of MnSOD into HepG2 cells. Western blot and catalase
activity assay showed that higher amounts of catalase were present in
mitochondria of these cells, compared with mitochondria from cells
transfected with plasmid containing only catalase cDNA or cells
transfected with empty vector or parental HepG2 cells. Thus, the MnSOD
leader sequence could be used to successfully import catalase into
mitochondria. Most of the increase in cellular catalase content and
activity in the mC5 (and in mC26) clones is due to the expression of
catalase in the mitochondrial fraction of these cells with just a small increase in cytosolic catalase.
Intracellular hydrogen peroxide generation induced by exogenous
H2O2 or AA was suppressed by cytosolic catalase
and by mitochondrial catalase. In general, the overexpression of
cytosolic and mitochondrial catalase was equally effective in lowering
DCF-DA fluorescence induced by exogenous H2O2
or by AA.
The overexpression of catalase in the cytosol and mitochondria
protected the cells from cytotoxicity caused by menadione. Comparing
C33 and mC5 cells, the cytosol catalase showed stronger protective
effect than the mitochondria catalase at higher menadione concentrations. However, comparable protection against menadione toxicity was observed in the C1 and mC26 clones (data not shown). Cytosolic catalase and mitochondrial catalase equally protected cells
from cytotoxicity induced by H2O2 and AA.
Mitochondrial catalase was protective against exogenously added
H2O2, which suggests that some of the added
H2O2 diffuses into the mitochondria and perhaps
damage to the mitochondria is an important factor contributing to
H2O2 toxicity. Similarly, cytosolic catalase
was protective against AA-induced H2O2
production and toxicity, which suggests that mitochondrially produced
H2O2 diffuses into the cytosol where it may
exert cytotoxic action. It would appear that catalase produced in any
cellular compartment might act as a sink for
H2O2 and promote H2O2
movement down its concentration gradient. There are reports that
catalase added to the culture medium might protect cells against
oxidant-induced injury; while this may reflect some uptake of catalase
into the cells by endocytosis, it may also reflect the removal of
diffusable H2O2 from the cell.
Under physiological conditions, H2O2 may play
an important role in signal transduction pathways (28), and activation
of the transcription factor NF- Mitochondria permeability transition (MPT) and mitochondrial membrane
potential ( Both bcl-2 and bcl-xL prevent cell death by inhibiting the loss of
mitochondrial membrane potential and by inhibiting the release of
cytochrome C or other apoptotic-inducing factors from mitochondria to
cytosol (39-42). bcl-2 prevents cells from undergoing necrosis caused
by inhibitors of the respiratory chain (chemical hypoxia) (43). Heat
shock protein 70 also can prevent changes in mitochondrial membrane
potential induced by H2O2 (44). These experiments demonstrate that protection of mitochondria might be an
important target for prevention against oxidative injury. Overexpression of phospholipid hydroperoxide glutathione peroxidase in
mitochondria was much more effective than overexpression in the cytosol
of RBL-2H3 cells in protecting from oxidative injury (45). We found
that cytosolic and mitochondrial catalase were equally effective in
preventing loss of In summary, the present study suggests that mitochondria are an
important target for oxidative damage and that both catalase in cytosol
and catalase in mitochondria are capable of protecting HepG2 cells
against cytotoxicity or apoptosis induced by oxidative stress.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
2 at the NADH dehydrogenase and ubisemiquinone
intermediate steps of the mitochondrial respiratory chain (1, 2).
Superoxide can be readily converted by mitochondrial superoxide
dismutase (MnSOD) into H2O2 (3). The primary
cellular enzymatic defense systems against hydrogen peroxide are the
glutathione redox cycle and catalase. GSH is a cofactor for glutathione
peroxidase, which converts H2O2 to
H2O at the expense of oxidizing GSH to its disulfide form
(GSSG). Glutathione reductase regenerates GSH from GSSG, using reducing
equivalents from NADPH (4). Catalase also protects cells from the
accumulation of H2O2 by converting it to
H2O and O2 (5). The glutathione redox cycle
system exists in both the cytosol and mitochondrial compartments of the
cell. However, catalase is present only or primarily in the peroxisome fraction and is absent in mitochondria of mammalian cells, except rat
heart mitochondria (6). Therefore, the only enzymatic defense system
against hydrogen peroxide in mitochondria is the glutathione redox
cycle system.
(15). It might also contribute to human diseases such as Alzheimer's disease, diabetes, stroke, and AIDS dementia complex (16-18). Studies in our laboratory indicate that CYP 2E1-dependent
cytotoxicity or apoptosis by ethanol to HepG2 cells was due to the
generation of ROS such as H2O2 (19, 20).

). Such conditions can cause
the release of cytochrome c from the mitochondria to the
cytosol, thereby triggering cells to undergo apoptosis by activating
caspase 3 (21). There are no reports on the possible protective actions
caused by expression of functionally active catalase in the
mitochondrial compartment against toxicity by ROS. In this study,
stable HepG2 cell lines that constitutively express catalase in the
mitochondrial compartment were developed. The main goal of the present
study was to compare the effect of overexpression of human catalase in
the cell cytosol to that in the mitochondria on the ability to protect
cells from cytotoxicity or apoptosis induced by hydrogen peroxide and
AA.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
A240 nm (1 min) × 1000/43.6 × mg protein.
A630 was taken as
the index of cell viability, The net absorbance from the wells of cells cultured with control medium was taken as the 100% viability value. The percentage of viability of the treated cells was calculated by the
formula (A570
A630)sample/(A570
A630)control × 100.
20 °C overnight. The precipitates were
collected by centrifugation at 13000 × g for 10 min.
The pellets were air-dried, resuspended with 50 µl of TE buffer
supplemented with 100 µg/ml RNase A and incubated at 37 °C for 30 min. DNA was loaded onto a 1.5% agarose gel containing ethidium
bromide, electrophoresed in TAE buffer for 2 h at 50 V, and
photographed under UV illumination.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 1.
Expression of catalase in different
transfected clones and parent HepG2 cells. Ten micrograms of
protein from cellular extraction (a) or from mitochondrial
extraction (b) were loaded into each lane for 10% SDS-PAGE,
followed by Western blot analysis with polyclonal rabbit anti-human
catalase antibody as described under "Materials and Methods."
Lane 1, HepG2 cells (H);
lane 2, cells transfected with empty vector
(Hp); lanes 3 and 4, two different
clones transfected with catalase (C1, C33);
lanes 5 and 6, two different clones
transfected with catalase with a mitochondria leader sequence
(mC5, mC26).

View larger version (18K):
[in a new window]
Fig. 2.
Catalase activity in different transfected
clones and parental HepG2 cells. Ten micrograms of protein from
cellular extraction (a) or from mitochondrial extraction
(b) were used to measure the catalytic activity of catalase.
Specific catalase units (units/mg protein/min) were calculated as
described under "Materials and Methods." Bar 1, HepG2 cells; bar 2, cells
transfected with empty vector (Hp); bars 3 and 4, two different clones transfected with
catalase (C1, C33); bars 5 and 6, two different clones transfected with catalase with a
mitochondria leader sequence (mC5, mC26). Data
are mean ± S.E. of triplicate experiments.

View larger version (41K):
[in a new window]
Fig. 3.
Determination of intracellular
H2O2. A, cells were treated
with buffer (first set of bars) or 15 µM AA (second set) or 500 µM H2O2 (third set) for 2 h, followed by incubation with 5 µM 2',7'-DCF-DA for 30 min. Cells were washed in PBS,
trypsinized, resuspended in PBS, and the intensity of fluorescence was
immediately read in a fluorescence spectrophotometer at wavelengths of
503 nm for excitation and at 529 nm for emission. The results were
expressed as relative units with the fluorescence intensity of control
Hp cells assigned a value of 1. Data are mean ± S.E. of
triplicate experiments. B, cells were grown on slides. After
treatment with 500 µM H2O2 for
2 h followed by 5 µM 2',7' DCF-DA for 30 min, cells
were washed in PBS, observed under the confocal microscope, and
pictures taken. a, Hp cells; b, C33 cells;
c, mC5 cells.

View larger version (15K):
[in a new window]
Fig. 4.
Cytotoxicity of menadione to different cell
lines. HepG2 (
), Hp (
), C33 (
), and mC5 (
) cells were
exposed to different concentrations of menadione for 18 h. Cell
viability was detected by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium method. The
percentage of viability of the treated cells was calculated by the
formula (A570
A630)
sample/(A570
A630)control × 100.

View larger version (11K):
[in a new window]
Fig. 5.
Cytotoxicity of H2O2
and AA to different cell lines. Hp (
), C33(
), and mC5(
)
cells were seeded onto 24-well plates and incubated with medium
containing 0.3 mM BSO for 16 h, followed by incubation
with medium containing 100 µM
H2O2 (a) and 15 µM AA
(b). At different time points, cells were trypsinized,
diluted, and stained with 0.2% trypan blue. The number of cells
excluding or staining for trypan blue were counted under the light
microscope. Cell viability was expressed as the percentage of the cells
excluding trypan blue out of the total number of cells. Data are the
mean ± S.E. of triplicate experiments.

View larger version (78K):
[in a new window]
Fig. 6.
DNA fragmentation induced by
H2O2 in different transfected cell lines.
Cells were seeded onto six-well plates and pretreated with 0.3 mM BSO for 16 h, followed by treatment with 100 µM H2O2 for 48 h. DNA was
extracted and electrophoresed on a 1.5% agarose gel as described under
"Materials and Methods." Lane 1, 100-base
pair standard ladder; lanes 2, 3,
4, and 5 were HepG2, Hp, C33, and mC5 cells
pretreated with BSO for 16 h, followed by treatment with 100 µM H2O2 for 48 h.

View larger version (26K):
[in a new window]
Fig. 7.
DNA analysis by flow cytometry. Hp, C33,
or mC5 cells were seeded onto six-well plates and incubated with medium
containing 0.3 mM BSO for 16 h, followed by incubation
with medium containing 100 µM
H2O2. At different time points, cells were
harvested by trypsinization and washed with PBS, followed by
centrifugation. The cell pellet was resuspended in 80% ethanol and
stored at 4 °C for 24 h. Cells were washed twice with PBS,
resuspended in PBS containing 100 µg/ml RNase, and incubated at
37 °C for 30 min. The cells were stained with PI, and analyzed by
flow cytometry. A, flow cytometry DNA histographs of Hp
(a, d, g), C33 (b,
e, h), and mC5 (c, f,
i) cells treated with 100 µM
H2O2 for 0 h (a, b,
c), 8 h (d, e, f), or
24 h (g, h, i). The percentage of
cells in the zone 1 hypodiploid area is depicted on the graphs.
B, bar graph showing the percentage of
apoptotic cells measured by flow cytometry. Bar 1, cells incubated with control medium; bar 2, BSO-treated cells; bar 3, BSO
treatment followed by 100 µM H2O2
for 4 h; bar 4, BSO + 100 µM
H2O2 for 8 h; bar 5,
BSO + 100 µM H2O2 for 12 h;
bar 6, BSO + 100 µM
H2O2 for 24 h. Data are expressed as
mean ± S.E.

) and the Integrity of the
Plasma Membrane--
Rh123, a lipophilic cation, is selectively taken
up by mitochondria, and uptake is directly proportional to
mitochondrial 
(26, 27). PI is imported into cells and binds to
cellular DNA when the integrity of the plasma membranes is lost. After incubation with BSO, those Hp, C33, and mC5 cells not treated with
H2O2 or AA were predominantly located in the
PI-negative and high 
(strong Rh123 fluorescence) field
(PI(
)-
high) reflective of viable, intact cells (Fig.
8, a-c, and insets
a-c). A small percentage of cells were located in the
(PI(+)-
low) field, reflective of damaged cells (Fig. 8,
a-c). Hp cells that were pretreated with 0.3 mM
BSO for 16 h followed by incubation with 100 µM
H2O2 for 24 h moved to the (PI(
)-
low) and (PI(+)-
low) field, and 67% of the cells displayed low
Rh123 intensity (Fig. 8d, M1 population, compared with 27%
of Hp control cells in panel a). However, only
42% and 30% of C33 and mC5 cells treated with
H2O2 were present in the 
low field,
respectively (Fig. 8, e and f). Hp cells
incubated with 15 µM AA for 8 h also moved to the
(PI(+)-
low) field, and 72% of the cells displayed low Rh123
intensity (Fig. 8g, M1 population). However, only
29% and 34% of C33 and mC5 cells were present in the 
low
field, respectively (Fig. 8, h and i). These
results indicate that both cytosolic catalase and mitochondrial
catalase protected the cells from loss of mitochondrial membrane
potential and loss of membrane integrity produced by either
H2O2 or AA.

View larger version (57K):
[in a new window]
Fig. 8.
Flow cytometry analysis of the mitochondrial
membrane potential. Hp, C33, and mC5 cells were seeded onto
six-well plates and incubated with medium containing 0.3 mM
BSO for 16 h, followed by incubation with 100 µM
H2O2 for 24 h or 15 µM AA
for 8 h, The cells were then incubated with medium containing 5 µg/ml Rh123 for 1 h. Cells were harvested by trypsinization and
resuspended in 1 ml of MEM medium containing 5 µg of PI. The
intensity of fluorescence from PI and Rh123 was analyzed by flow
cytometry. Panels a, b, and
c refer to Hp, C33, and mC5 cells, respectively, incubated
just with culture medium. Cells not treated with
H2O2 or AA were predominantly located in the
PI-negative and high 
(Rh123-positive) field (PI(
)-
high)
while a smaller percentage of cells were in the (PI(+)-
low)
field (insets of a-c). Panels d, e, and f refer to Hp, C33, and mC5
cells incubated with 100 µM H2O2
for 24 h. Panels g, h, and
i refer to Hp, C33, and mC5 cells incubated with 15 µM AA for 8 h. M1 and M2 are
two population of cells with low and high Rh123 fluorescence intensity,
and the percentage of cells with low Rh123 fluorescence is shown in
each panel. The figure is one representative experiment out of
three.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
B (29). However, under pathogenic conditions, H2O2 can produce apoptosis or
necrosis (30, 31). HepG2 cells pretreated with BSO followed by exposure
to 100 µM H2O2 could undergo
apoptosis as a DNA ladder was detected in parental HepG2 and Hp cells
after 48 h of incubation. Consistent with the protection afforded
by cytosolic or mitochondrial catalase, a DNA ladder was not detected
in the C33 and mC5 cells under the same conditions. Flow cytometry DNA
analysis showed that 48% of Hp cells were in the apoptotic zone after
incubation with BSO and 100 µM
H2O2 for 24 h. However, only 17% and 6%
percent apoptotic cells were detected in C33 and mC5 cells,
respectively, under the same conditions. Thus both mitochondrial
catalase and cytosolic catalase protect HepG2 cells from apoptosis
induced by H2O2. It is also likely that some of
the H2O2 toxicity may be necrotic in nature;
for example, a DNA ladder was observed at 48 h but not at 24 h after treatment with 100 µM
H2O2, yet 75% of Hp cells lost their viability
at 24 h (Fig. 5). It would appear that cytosolic and mitochondrial
catalase can protect against the apoptotic and the necrotic effects of
H2O2.

) are markers for mitochondrial damage and dysfunction
(32-34). Mitochondrial dysfunction caused by ROS, especially
H2O2, can lead to necrosis and apoptosis (22,
35-38). We determined the mitochondrial membrane potential in Hp, C33, and mC5 cells pretreated with 0.3 mM BSO followed by
incubation with either 100 µM
H2O2 or 15 µM AA. The decline in

caused by these agents was much less in C33 and mC5 cells than
the Hp cells. These results suggest that both cytosolic catalase and mitochondrial catalase protected cells from oxidant-induced loss of
mitochondrial potential, which may play an important role in the
overall protection against oxidant-induced cytotoxicity.

and loss of cellular viability. Perhaps one
advantage of catalase over the GSH-glutathione peroxidase system in
these actions is the lack of requirement for recycling of GSH and
consumption of NADPH and perhaps avoiding the accumulation of GSSG and
mixed protein disulfides.
| |
FOOTNOTES |
|---|
* This work was supported by Grant AA 03312 from the NIAAA and CA 77068 from NCI National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom all correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, Mount Sinai School of Medicine, Box 1020, One Gustave L. Levy Pl., New York, NY 10029. Tel.: 212-241-7285; Fax: 212-996-7214; E-mail: acederb@smtplink.mssm.edu.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
ROS, reactive oxygen
species;
MnSOD, manganese superoxide dismutase;
BSO, L-buthionine sulfoximine;
DCF-DA, 2',7'-dichlorofluorescein
diacetate;
DCF, 2',7'-dichlorofluorescein;
DCFG, 2',7'-dichlorofluorescein;
AA, antimycin A;
PI, propidium iodide;
Rh123, rhodamine 123;

, mitochondrial membrane potential;
PAGE, polyacrylamide gel electrophoresis;
PBS, phosphate-buffered saline;
CMV, cytomegalovirus;
CAT, chloramphenicol acetyltransferase;
MEM, minimal essential medium.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Boveris, A., and Chance, B. (1973) Biochem. J. 134, 707-716[Medline] [Order article via Infotrieve] |
| 2. | Turrens, J. F. (1997) Biosci. Rep. 17, 3-8[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Fridovich, I.
(1997)
J. Biol. Chem.
272,
18515-18517 |
| 4. | Meister, A., and Anderson, M. E. (1983) Annu. Rev. Biochem. 52, 711-760[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Michiels, C., Raes, M., Toussaint, O., and Remacle, J. (1994) Free Radical Biol. Med. 17, 235-248[CrossRef][Medline] [Order article via Infotrieve] |
| 6. |
Radi, R.,
Turrens, J. F.,
Chang, L. Y.,
Bush, K. M.,
Crapo, J. D.,
and Freeman, B. A.
(1991)
J. Biol. Chem.
266,
22028-22034 |
| 7. | Burdon, R. H. (1995) Free Radical Biol. Med. 18, 775-794[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Henle, E. S.,
and Linn, S.
(1997)
J. Biol. Chem.
272,
19095-19098 |
| 9. | Dringen, R., and Hamprecht, B. (1997) Brain Res. 759, 67-75[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Lennon, S. V., Martin, S. J., and Cotter, T. G. (1991) Cell Prolif. 24, 203-214[Medline] [Order article via Infotrieve] |
| 11. | Hampton, M. B., and Orrenius, S. (1997) FEBS Lett. 414, 552-556[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Quillet-Mary, A.,
Jaffrezou, J. P.,
Mansat, V.,
Bordier, C.,
Naval, J.,
and Laurent, G.
(1997)
J. Biol. Chem.
272,
21388-21395 |
| 13. |
Hagar, H.,
Ueda, N.,
and Shah, S. V.
(1996)
Am. J. Physiol.
271,
F209-F215 |
| 14. | Chen, Y. C., Lin-Shiau, S. Y., and Lin, J. K. (1998) J. Cell. Physiol. 177, 324-333[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Sidoti-de Fraisse, C., Rincheval, V., Risler, Y., Mignotte, B., and Vayssiere, J. L. (1998) Oncogene 17, 1639-1651[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Markesbery, W. R. (1997) Free Radical Biol. Med. 23, 134-147[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Tritschler, H. J., Packer, L., and Medori, R. (1994) Biochem. Mol. Biol. Int. 34, 169-181[Medline] [Order article via Infotrieve] |
| 18. | Singh, K. (1997) Indian J. Med. Sci. 51, 226-230[Medline] [Order article via Infotrieve] |
| 19. |
Chen, Q.,
and Cederbaum, A. I.
(1998)
Mol. Pharmacol.
53,
638-648 |
| 20. |
Wu, D.,
and Cederbaum, A. I.
(1996)
J. Biol. Chem.
271,
23914-23919 |
| 21. | Tada-Oikawa, S., Oikawa, S., Kawanishi, M., Yamada, M., and Kawanishi, S. (1999) FEBS Lett. 442, 65-69[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Melendez, J. A.,
and Davies, K. J. A.
(1996)
J. Biol. Chem.
271,
18898-18903 |
| 23. | Sims, N. R. (1990) J. Neurochem. 55, 698-707[Medline] [Order article via Infotrieve] |
| 24. |
Claiborne, A.,
and Fridovich, I.
(1979)
J. Biol. Chem.
254,
4245-4252 |
| 25. |
Chen, Q.,
Galleano, M.,
and Cederbaum, A. I.
(1997)
J. Biol. Chem.
272,
14532-14541 |
| 26. |
Davis, S.,
Weiss, M. J.,
Wong, J. R.,
Lampidis, T. J.,
and Chen, L. B.
(1985)
J. Biol. Chem.
260,
13844-13850 |
| 27. | Skowronek, P., Krummeck, G., Haferkamp, O., and Rodel, G. (1990) Curr. Genet. 18, 265-267[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Lander, H. M.,
Ogiste, J. S.,
Teng, K. K.,
and Novogrodsky, A.
(1995)
J. Biol. Chem.
270,
21195-21198 |
| 29. | Piette, J., Piret, B., Bonizzi, G., Schoonbroodt, S., Merville, M. P., Legrand-Poels, S., and Bours, V. (1997) Biol. Chem. 378, 1237-1245[Medline] [Order article via Infotrieve] |
| 30. | Matsura, T., Kai, M., Fujii, Y., Ito, H., and Yamada, K. (1999) Free Radical Res. 30, 73-83[CrossRef][Medline] [Order article via Infotrieve] |
| 31. | Teramoto, S., Tomita, T., Matsui, H., Ohga, E., Matsuse, T., and Ouchi, Y. (1999) Jpn. J. Pharmacol. 79, 33-40[CrossRef][Medline] [Order article via Infotrieve] |
| 32. | Lemasters, J. J., Qian, T., Elmore, S. P., Trost, L. C., Nishimura, Y., Herman, B., Bradham, C. A., Brenner, D. A., and Nieminen, A. L. (1998) Biofactors 8, 283-285[Medline] [Order article via Infotrieve] |
| 33. | Gores, G. J., Miyoshi, H., Botla, R., Aguilar, H. I., and Bronk, S. F. (1998) Biochim. Biophys. Acta 1366, 167-175[Medline] [Order article via Infotrieve] |
| 34. | Hirokawa, M., Miura, S., Yoshida, H., Kurose, I., Shigematsu, T., Hokari, R., Higuchi, H., Watanabe, N., Yokoyama, Y., Kimura, H., Kato, S., and Ishii, H. (1998) Alcohol Clin. Exp. Res. 22 suppl., 111S-114S[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Lehninger, A. L.,
Vercesi, A.,
and Bababunmi, E. A.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
1690-1694 |
| 36. | Vercesi, A. E. (1984) Biochem. Biophys. Res. Commun. 119, 305-310[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Castilho, R. F., Kowaltowski, A. J., and Vercesi, A. E. (1998) Arch. Biochem. Biophys. 354, 151-157[CrossRef][Medline] [Order article via Infotrieve] |
| 38. |
Kowaltowski, A. J.,
Netto, L. E.,
and Vercesi, A. E.
(1998)
J. Biol. Chem.
273,
12766-12769 |
| 39. | Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T., and Thompson, C. B. (1997) Cell 91, 627-637[CrossRef][Medline] [Order article via Infotrieve] |
| 40. |
Yang, J.,
Liu, X.,
Bhalla, K.,
Kim, C. N.,
Ibrado, A. M.,
Cai, J.,
Peng, T. I.,
Jones, D. P.,
and Wang, X.
(1997)
Science
275,
1129-1132 |
| 41. | Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996) Cell 86, 147-157[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Zhang, P.,
Liu, B.,
Kang, S. W.,
Seo, M. S.,
Rhee, S. G.,
and Obeid, L. M.
(1997)
J. Biol. Chem.
272,
30615-30618 |
| 43. | Shimizu, S., Eguchi, Y., Kamiike, W., Waguri, S., Uchiyama, Y., Matsuda, H., and Tsujimoto, Y. (1996) Oncogene 13, 21-29[Medline] [Order article via Infotrieve] |
| 44. |
Polla, B. S.,
Kantengwa, S.,
Francois, D.,
Salvioli, S.,
Franceschi, C.,
Marsac, C.,
and Cossarizza, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6458-6463 |
| 45. |
Arai, M.,
Imai, H.,
Koumura, T.,
Yoshida, M.,
Emoto, K.,
Umeda, M.,
Chiba, N.,
and Nakagawa, Y.
(1999)
J. Biol. Chem.
274,
4924-4933 |
This article has been cited by other articles:
![]() |
S Prasad, N Kalra, S Srivastava, and Y Shukla Regulation of oxidative stress-mediated apoptosis by diallyl sulfide in DMBA-exposed Swiss mice Human and Experimental Toxicology, January 1, 2008; 27(1): 55 - 63. [Abstract] [PDF] |
||||
![]() |
K. M. Connor, N. Hempel, K. K. Nelson, G. Dabiri, A. Gamarra, J. Belarmino, L. Van De Water, B. M. Mian, and J. A. Melendez Manganese Superoxide Dismutase Enhances the Invasive and Migratory Activity of Tumor Cells Cancer Res., November 1, 2007; 67(21): 10260 - 10267. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-H. Liu, T.-S. Wu, F.-Y. Yu, and C.-C. Su Induction of Oxidative Stress Response by the Mycotoxin Patulin in Mammalian Cells Toxicol. Sci., February 1, 2007; 95(2): 340 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, D. H. Daniels, C. Asbury, S. Venkataraman, J. Liu, D. R. Spitz, L. W. Oberley, and J. J. Cullen Mitochondrial Production of Reactive Oxygen Species Mediate Dicumarol-induced Cytotoxicity in Cancer Cells J. Biol. Chem., December 8, 2006; 281(49): 37416 - 37426. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bai and A. I. Cederbaum Cycloheximide Protects HepG2 Cells from Serum Withdrawal-Induced Apoptosis by Decreasing p53 and Phosphorylated p53 Levels J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1435 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gong and A. I. Cederbaum Transcription Factor Nrf2 Protects HepG2 Cells against CYP2E1 plus Arachidonic Acid-dependent Toxicity J. Biol. Chem., May 26, 2006; 281(21): 14573 - 14579. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Nelson, S. Subbaram, K. M. Connor, J. Dasgupta, X.-F. Ha, T.-C. Meng, N. K. Tonks, and J. A. Melendez Redox-dependent Matrix Metalloproteinase-1 Expression Is Regulated by JNK through Ets and AP-1 Promoter Motifs J. Biol. Chem., May 19, 2006; 281(20): 14100 - 14110. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Arita, S. H. Harkness, J. A. Kazzaz, H.-c. Koo, A. Joseph, J.A. Melendez, J. M. Davis, A. Chander, and Y. Li Mitochondrial localization of catalase provides optimal protection from H2O2-induced cell death in lung epithelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L978 - L986. [Abstract] [Full Text] [PDF] |
||||
![]() |